Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice

Journal of Experimental Medicine

Volumn 193, Issue 5, 2001, Pages 651-659

  Miura, Yoshiharu ^a,b   Misawa, Naoko ^a   Maeda, Naoyoshi ^a   Inagaki, Yoshio ^b   Tanaka, Yuetsu ^c   Ito, Mamoru ^d   Kayagaki, Nobuhiko ^a   Yamamoto, Naoki ^b   Yagita, Hideo ^e   Mizusawa, Hidehiro ^b   Koyanagi, Yoshio ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

^d CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^e JUNTENDO UNIVERSITY   (Japan)

Author keywords

Apoptosis; HIV 1; Hu PBL NOD SCID mouse; TRAIL; TUNEL

Indexed keywords

CD4 ANTIGEN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; HIV INFECTIONS; HIV-1; HUMANS; IN SITU NICK-END LABELING; LYMPHOCYTE TRANSFUSION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; SPLEEN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035809318     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.193.5.651     Document Type: Article

References (43)

1. Changes in thymic function with age and during the treatment of HIV infection
2. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden
3. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
4. + T cells from human immunodeficiency virus-infected asymptomatic individuals
5. Programmed death of T cells in HIV-1 infection
6. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals
7. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: Differential ligation constantly induces apoptosis
8. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children
9. + T cells from human immunodeficiency virus-infected persons: Differential in vitro preventive effect of cytokines and protease antagonists
10. Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals
11. Fas ligand deficiency in HIV disease
12. Identification and characterization of a new member of the TNF family that induces apoptosis
13. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
14. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL
15. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression
16. Measles virus induces functional TRAIL production by human dendritic cells
17. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection
18. TRAIL/Apo-2-ligand-induced apoptosis in human T cells
19. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
20. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
21. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain
22. + T cells in vitro and in vivo
23. + T cell-mediated cytotoxicity
24. Chemotactic activity of soluble Fas ligand against phagocytes
25. Periodate-lysine-paraformaldehyde fixative. A new fixative for immunoelectron microscopy
26. Selection of a fixative for identifying T cell subsets, B cells, and macrophages in paraffin-embedded mouse spleen
27. The EnVision++ system: A new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques
28. Enhancement of immunohistochemical detection of HIV-1 p24 antigen in brain by tyramide signal amplification
29. Pathogenesis of HIV and SIV
30. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4
31. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
32. Viral dynamics in hmnan immunodeficiency virus type 1 infection
33. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
34. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp 120
35. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles
36. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: Evidence for TRAIL induction via the T cell receptor signaling pathway
37. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
38. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
39. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
40. Regulation of TRAIL sensitivity in primary and transformed human keratinocytes
41. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: Defective regulation of cytokine receptors and protein kinase C
42. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
43. Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice